CORE
🇺🇦
make metadata, not war
Services
Research
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Therapy with central active catechol-O-methyltransferase (COMT)-inhibitors: is addition of monoamine oxidase (MAO)-inhibitors necessary to slow progress of neurodegenerative disorders?
Author
A Ishii
A Laihinen
+46 more
A Langeloh
AM Honnegger
B Knusel
B Margolis
B Margolis
BL Chan
C Hyman
C Molloy
C Volonte
DR Kaplan
DR Sibley
DT Dexter
DT Dexter
G Z�richer
H Funakoshi
H Houchi
H Thoenen
H Thoenen
JM Cedarbaum
JO Rinne
JP Mitchell
JW Langston
L Varticowski
M Carman-Krzan
M Meyer
M Oshima
MBH Youdim
ME G�tz
MW Decker
N Nica Bhairid
NT Buu
P Riederer
PT M�nnisto
R Hellweg
R Levi-Montalcini
R Takeuchi
RE Heikkila
S Furukawa
S Furukawa
TS Elizan
W Birkmayer
WG Tatton
Y Furukawa
Y Furukawa
Y Furukawa
Y Matsui
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
No full text
